We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Diagnostics Emerging Rapidly for Routine Patient Care

By LabMedica International staff writers
Posted on 13 Jan 2009
Print article
The success of molecular diagnostics will result from the commercialization of rapid, user-friendly, inexpensive, and high-quality tests and, together with the discovery of molecular-based therapeutics, will allow for more individualized disease management.

The entire spectrum of disease management, from the early detection of disease, to defining the prognosis of disease evolution and predicting a patient's response to specific therapies will soon be transformed by molecular medicine.

As DNA-based diagnostic and therapeutic interventions come to market and are proven economically valuable, physicians will begin to rely on them for treating their patients. This will propel the molecular testing market, valued at US $3.7 billion in 2007, into double-digit annual growth through 2012.

Roche's (Basel, Switzerland) polymerase chain reaction (PCR) technology has dominated molecular testing since the mid-1980s. New technologies will soon take over from PCR--these include bead arrays, electrochemical arrays, microarrays, SNP-it. Products will need to be easily miniaturized and simplified for use in routine laboratories. New products offer faster turnaround of test results and standardization of a large menu of tests on a single platform. This is speeding the adoption of molecular assays in routine patient care.

The report was made available by Kalorama (Rockville, MD, USA), which provides independent market research in the life sciences, as well as a full range of custom research services. "The new molecular assays, techniques, and test services that have emerged in the past few years are directly related to the genomic information culled from sequencing the human genome and pathogenic organisms," noted Kalorama information analyst, Shara Rosen. "By the time DNA assays become part of the routine fabric of laboratory medicine in 2010 or so, it is expected that physicians around the world will rely on molecular assays in the treatment of their patients."

Related Links:
Roche
Kalorama



Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.